Kwality Pharma Financials
BSE: 539997
₹3,285.50
As on 04-Sep-2026 15:58IST
Market cap
₹3,418 Cr
Revenue (TTM)
₹554 Cr
P/E Ratio
42.2
P/B Ratio
9.6
Div. Yield
0 %
Income Statement (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Operating Revenue
|
553.96
|
503.08
|
370.20
|
307.17
|
251.03
|
456.19
|
|||||
|
Total Income
|
557.06
|
505.94
|
372.12
|
309.00
|
253.97
|
459.70
|
|||||
|
Total Expenditure
|
418.87
|
384.84
|
289.81
|
240.86
|
190.30
|
284.52
|
|||||
|
EBITDA
|
135.08
|
118.24
|
80.39
|
66.31
|
60.73
|
171.66
|
|||||
|
Depreciation
|
20.04
|
19.81
|
18.29
|
19.56
|
14.96
|
10.69
|
|||||
|
EBIT
|
115.04
|
98.43
|
62.10
|
46.75
|
45.77
|
160.97
|
|||||
|
Interest
|
10.87
|
10.97
|
9.88
|
10.39
|
6.61
|
2.92
|
|||||
|
Other Income
|
3.11
|
2.86
|
1.92
|
1.83
|
2.94
|
3.51
|
|||||
|
Exceptional Items
|
-0.83
|
-0.83
|
--
|
-7.10
|
-16.53
|
--
|
|||||
|
Profit before Tax
|
106.45
|
89.49
|
54.14
|
31.10
|
25.57
|
161.57
|
|||||
|
Provision for Tax
|
25.40
|
22.15
|
14.34
|
7.48
|
6.29
|
41.63
|
|||||
|
Profit after Tax
|
81.04
|
67.35
|
39.80
|
23.62
|
19.28
|
119.94
|
|||||
|
Minority Interest
|
0.00
|
0.00
|
0.04
|
0.18
|
0.09
|
0.05
|
|||||
|
Share of Associate
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Consolidated Profit
|
81.05
|
67.35
|
39.85
|
23.80
|
19.37
|
119.99
|
Liabilities (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Shareholder's Funds
|
331.60
|
331.60
|
264.05
|
224.21
|
200.52
|
181.14
|
|||||
|
Minority Interest
|
0.00
|
-1.67
|
-1.65
|
-1.63
|
-1.45
|
-1.35
|
|||||
|
Non-Current Liabilities
|
36.77
|
34.27
|
13.76
|
19.75
|
28.62
|
21.32
|
|||||
|
Current Liabilities
|
225.52
|
225.52
|
169.51
|
151.85
|
125.95
|
139.49
|
|||||
|
Total Liabilities
|
592.21
|
592.21
|
447.27
|
394.21
|
353.63
|
340.59
|
Assets (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Non-Current Assets
|
175.08
|
184.03
|
161.88
|
151.49
|
146.43
|
112.77
|
|||||
|
Current Assets
|
405.68
|
405.68
|
283.78
|
242.69
|
207.20
|
227.82
|
|||||
|
Total Assets
|
592.21
|
592.21
|
447.27
|
394.21
|
353.63
|
340.59
|
|||||
|
Total Debt*
|
--
|
130.46
|
112.45
|
98.12
|
90.26
|
54.01
|
|||||
|
Net Current Assets
|
180.16
|
180.16
|
114.27
|
90.84
|
81.25
|
88.33
|
|||||
|
Contingent Liabilities
|
--
|
36.98
|
36.98
|
0.35
|
0.51
|
0.05
|
Cashflow (₹ Cr) |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Cash From Operating Activities
|
--
|
16.59
|
52.72
|
42.98
|
41.38
|
60.60
|
|||||
|
Cash Flow from Investing Activities
|
--
|
-34.91
|
-28.52
|
-26.40
|
-48.44
|
-62.93
|
|||||
|
Cash from Financing Activities
|
--
|
7.04
|
-14.44
|
-17.40
|
0.99
|
5.66
|
|||||
|
Net Cash Inflow / Outflow
|
--
|
-11.28
|
9.76
|
-0.81
|
-6.07
|
3.33
|
Financials Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Adjusted EPS (₹)
|
78.68
|
64.90
|
38.40
|
22.93
|
18.67
|
115.64
|
|||||
|
Cash EPS (₹)
|
78.11
|
84.00
|
55.99
|
41.61
|
33.00
|
125.89
|
|||||
|
Adjusted Book Value (₹)
|
343.49
|
318.80
|
253.70
|
215.31
|
192.48
|
173.81
|
|||||
|
Dividend per Share (₹)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
Cash Flow per Share (₹)
|
--
|
15.98
|
50.81
|
41.42
|
39.88
|
58.40
|
|||||
|
Free Cash Flow per Share (₹)
|
--
|
-43.55
|
18.75
|
-9.74
|
-11.97
|
2.22
|
Profitability Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
ROCE (%)
|
--
|
24.01
|
18.36
|
13.57
|
12.27
|
97.93
|
|||||
|
ROE (%)
|
26.26
|
22.67
|
16.36
|
11.16
|
10.15
|
99.66
|
|||||
|
ROA (%)
|
15.59
|
13.01
|
9.48
|
6.32
|
5.55
|
47.33
|
|||||
|
EBIT Margin (%)
|
20.77
|
19.57
|
16.77
|
15.22
|
18.23
|
35.29
|
|||||
|
Net Margin (%)
|
14.55
|
13.31
|
10.70
|
7.64
|
7.59
|
26.09
|
|||||
|
Cash Profit Margin (%)
|
--
|
17.32
|
15.69
|
14.06
|
13.64
|
28.64
|
Growth Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Revenue Growth (%)
|
37.94
|
35.90
|
20.52
|
22.36
|
-44.97
|
74.11
|
|||||
|
EBIT Growth (%)
|
68.71
|
58.51
|
32.82
|
2.16
|
-71.57
|
619.93
|
|||||
|
Net Profit Growth (%)
|
87.85
|
69.20
|
68.54
|
22.49
|
-83.93
|
705.63
|
|||||
|
EPS Growth (%)
|
86.48
|
69.02
|
67.44
|
22.83
|
-83.86
|
692.23
|
|||||
|
Book Value Growth (%)
|
--
|
25.66
|
17.83
|
11.86
|
10.74
|
198.82
|
Valuation Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Price / Earnings
|
42.17
|
20.13
|
22.63
|
17.85
|
16.47
|
5.02
|
|||||
|
Price / Book Value
|
9.59
|
4.10
|
3.43
|
1.90
|
1.60
|
3.34
|
|||||
|
Dividend Yield (%)
|
--
|
--
|
--
|
--
|
--
|
--
|
|||||
|
EV/EBITDA
|
25.65
|
12.24
|
12.14
|
7.59
|
6.31
|
3.67
|
|||||
|
Close Price (₹)
|
2,802.30
|
1,306.35
|
869.05
|
409.40
|
307.55
|
580.00
|
|||||
|
High Price (₹)
|
2,890.30
|
1,740.00
|
1,069.95
|
545.00
|
638.95
|
1,117.00
|
|||||
|
Low Price (₹)
|
828.80
|
666.00
|
414.00
|
248.00
|
265.60
|
53.00
|
|||||
|
Market Cap (₹ Cr)
|
3,417.82
|
1,355.51
|
901.73
|
424.79
|
319.11
|
601.82
|
Solvency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debt to Equity
|
0.09
|
0.39
|
0.43
|
0.44
|
0.45
|
0.30
|
|||||
|
Short term debt to equity ratio
|
--
|
0.26
|
0.32
|
0.29
|
0.25
|
0.13
|
|||||
|
Current Ratio
|
1.80
|
1.80
|
1.67
|
1.60
|
1.65
|
1.63
|
|||||
|
Quick Ratio
|
1.45
|
1.45
|
1.18
|
1.08
|
0.96
|
1.25
|
|||||
|
Interest Coverage
|
10.79
|
9.16
|
6.48
|
3.99
|
4.87
|
56.38
|
Operating Efficiency Ratios |
TTM | Mar-26 | Mar-25 | Mar-24 | Mar-23 | Mar-22 | Mar-21 | Mar-20 | Mar-19 | Mar-18 | Mar-17 |
|---|---|---|---|---|---|---|---|---|---|---|---|
|
Debtors to sales (%)
|
50.55
|
55.67
|
41.68
|
37.24
|
28.56
|
15.15
|
|||||
|
Asset Turnover
|
1.07
|
0.97
|
0.88
|
0.82
|
0.72
|
1.80
|
|||||
|
Receivable days
|
--
|
157.57
|
132.46
|
110.56
|
102.38
|
41.94
|
|||||
|
Inventory Days
|
--
|
58.67
|
79.79
|
97.85
|
101.54
|
28.29
|
|||||
|
Payable days
|
--
|
160.16
|
157.23
|
161.90
|
183.20
|
78.14
|
|||||
|
Cash Conversion Cycle
|
--
|
56.07
|
55.02
|
46.51
|
20.73
|
-7.91
|